1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 Growing Focus on Safety of Both Humans and Property 4.4 Market Restraints 4.4.1 Higher Setup Costs 4.5 Industry Attractiveness - Porter's Five Force Analysis 4.5.1 Threat of New Entrants 4.5.2 Bargaining Power of Buyers/Consumers 4.5.3 Bargaining Power of Suppliers 4.5.4 Threat of Substitute Products 4.5.5 Intensity of Competitive Rivalry 5 MARKET SEGMENTATION 5.1 By Application 5.1.1 Drug Discovery 5.1.2 Clinical Diagnosis 5.1.3 Microbiology Solutions 5.1.4 Genomics Solutions 5.1.5 Proteomics Solutions 5.2 By End User 5.2.1 Clinical Laboratory 5.2.2 Research Laboratory 5.3 Geography 5.3.1 North America 5.3.2 Europe 5.3.3 Asia-Pacific 5.3.4 Latin America 5.3.5 Middle East & Africa 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Hamilton Company 6.1.2 Peak Analysis & Automation (PAA) 6.1.3 PerkinElmer, Inc. 6.1.4 Thermo Fisher Scientific 6.1.5 Hudson Robotics, Inc. 6.1.6 Tecan Group 6.1.7 Anton Paar GmbH 6.1.8 Biomérieux SA 6.1.9 Beckman Coulter Inc. 6.1.10 Siemens AG 6.1.11 Cleveland Automation Engineering 6.1.12 QIAGEN NV 6.1.13 Abbott Laboratories 7 INVESTMENT ANALYSIS 8 MARKET OPPORTUNITIES AND FUTURE TRENDS